journal article·2022-06-10Open access

Comparative Study on Bioactive Filler/Biopolymer Scaffolds for Potential Application in Supporting Bone Tissue Regeneration

Micaela Degli Esposti, Maryam Changizi, Roberta Salvatori, Luigi Chiarini, Valeria Cannillo, Davide Morselli, Paola Fabbri

ACS Applied Polymer Materials· Volume 4· Issue 6

Abstract

The combination of biopolymers and bioactive inorganic particles for bone tissue regeneration has been investigated in the last decades. However, several studies report discordant results on the specific synergistic effect of the compounds. A comparative study on porous scaffolds obtained by the combination of the most promising biopolymers and bioactive inorganic particles is herein reported. Specifically, porous scaffolds have been fabricated by the Thermally Induced Phase Separation method using poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), poly(lactic acid) (PLA), and poly(caprolactone) (PCL) compounded with hydroxyapatite (HAp), calcium silicate (CS), or a Mg-and Sr-rich bioglass (BG) with a nominal composition of 2.3% Na 2 O, 2.3% K 2 O, 25.6% CaO, 10.0% MgO, 10.0% SrO, 2.6% P 2 O 5 , and 47.2% SiO 2 . Morphological analyses revealed the formation of highly interconnected and aligned open pores. Both thermal investigations and compressive tests highlight the close similarity between PLA-and PHBV-based scaffolds in terms of the amorphous structure and stiffness when the fillers are added. On the other hand, the addition of amorphous BG in semicrystalline PCL shows a decrease of the crystallinity degree of the polymer and a consequent decrease of the compressive modulus. Preliminary in vitro investigations (direct and indirect contact tests) carried out on the composite systems revealed that all the prepared materials provide an appropriate environment for NIH 3T3 cell adhesion and proliferation, showing a total lack of cytotoxicity. The addition of all the inorganic fillers has an overall positive effect on cell proliferation, viability (Neutral Red uptake), and metabolic activity (MTT test). Interestingly, this effect is particularly evident whenever BG is added. The combination of both amorphous BGs with amorphous polymers, such as PLA and PHBV, seems to be responsible for creating the best microenvironmental cue for NIH 3T3 cell attachment and proliferation.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · biodegradable polymer synthesis and properties · Dental materials and restorations

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Civil, Chemical, Environmental, and Materials Engineering, Università di Bologna, Via Terracini 28, 40131 Bologna, Italy

National Interuniversity Consortium of Materials Science and Technology (INSTM), Via Giusti 9, 50121 Firenze, Italy

Biomaterials Laboratory, Department of Medical and Surgical Sciences of Children and Adults, Università di Modena e Reggio Emilia, Via Campi 213/A, 41125 Modena, Italy

Department of Engineering “Enzo Ferrari”, Università di Modena e Reggio Emilia, Via Vivarelli 10, 41125 Modena, Italy

References (70)

Show source-provided references
1. 10.1016/j.addr.2015.03.01310.1016/j.addr.2015.03.013 ↗
2. 10.1007/s00586-008-0745-310.1007/s00586-008-0745-3 ↗
3. 10.1016/j.biomaterials.2006.01.03910.1016/j.biomaterials.2006.01.039 ↗
4. 10.1016/j.polymdegradstab.2010.06.00710.1016/j.polymdegradstab.2010.06.007 ↗
5. 10.3390/ma1323556010.3390/ma13235560 ↗
6. 10.1016/j.compositesb.2021.10890310.1016/j.compositesb.2021.108903 ↗
7. 10.1021/acsbiomaterials.1c0075710.1021/acsbiomaterials.1c00757 ↗
8. 10.1002/jbm.b.3310110.1002/jbm.b.33101 ↗
9. 10.1016/j.compositesb.2021.10919210.1016/j.compositesb.2021.109192 ↗
10. 10.3390/ma307386710.3390/ma3073867 ↗
11. 10.1016/j.progsolidstchem.2004.07.00110.1016/j.progsolidstchem.2004.07.001 ↗
12. 10.1016/j.dental.2015.01.00410.1016/j.dental.2015.01.004 ↗
13. 10.1016/j.matlet.2020.12838910.1016/j.matlet.2020.128389 ↗
14. 10.3390/nano1003043210.3390/nano10030432 ↗
15. 10.3390/nano1002024310.3390/nano10020243 ↗
16. 10.1002/jbm.a.3427110.1002/jbm.a.34271 ↗
17. 10.1016/j.compositesb.2021.10879010.1016/j.compositesb.2021.108790 ↗
18. 10.1063/1.486516810.1063/1.4865168 ↗
19. 10.1016/j.msec.2019.03.01410.1016/j.msec.2019.03.014 ↗
20. 10.1016/j.matlet.2017.11.02010.1016/j.matlet.2017.11.020 ↗
21. 10.1021/am500845x10.1021/am500845x ↗
22. 10.1038/nmeth.201910.1038/nmeth.2019 ↗
23. Ente Nazionale Italiano di Unificazione. UNI EN 1936:2007, Natural Stone Test Methods - Determination of Real Density and Apparent Density, and of Total and Open Porosity. 2007.
24. 10.1002/(SICI)1097-0126(199603)39:3<215::AID-PI497>3.0.CO;2-010.1002/(SICI)1097-0126(199603)39:3<215::AID-PI497>3.0.CO;2-0 ↗
25. 10.1016/0014-3057(72)90109-710.1016/0014-3057(72)90109-7 ↗
26. International Organization for Standardization. ISO 10993-1:2009, Biological Evaluation of Medical Devices - Part 1: Evaluation and Testing within a Risk Management Process. 2009.
27. International Organization for Standardization. ISO 10993-12:2012, Biological Evaluation of Medical Devices - Part 12: Sample Preparation and Reference Materials. 2012.
28. International Organization for Standardization. ISO 10993-5:2009, Biological Evaluation of Medical Devices - Part 5: Tests for in Vitro Cytotoxicity. 2009.
29. 10.1021/bm060317c10.1021/bm060317c ↗
30. 10.1016/j.biomaterials.2003.10.08210.1016/j.biomaterials.2003.10.082 ↗
31. 10.1016/j.actbio.2008.11.02510.1016/j.actbio.2008.11.025 ↗
32. 10.3390/ijms2207350410.3390/ijms22073504 ↗
33. 10.1016/j.msec.2017.08.04010.1016/j.msec.2017.08.040 ↗
34. 10.1016/j.msec.2019.04.04010.1016/j.msec.2019.04.040 ↗
35. Bassi A. · 2011 · 9310.1533/9780857092915.2.93 ↗
36. 10.1016/j.actbio.2006.07.01210.1016/j.actbio.2006.07.012 ↗
37. 10.1016/j.msec.2015.12.08710.1016/j.msec.2015.12.087 ↗
38. 10.1016/j.biomaterials.2005.02.00210.1016/j.biomaterials.2005.02.002 ↗
39. Martínez-Pérez C. A. · 2011
40. 10.1016/j.actbio.2009.03.01710.1016/j.actbio.2009.03.017 ↗
41. 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H ↗
42. 10.1002/(SICI)1097-4636(19990315)44:4<446::AID-JBM11>3.0.CO;2-F10.1002/(SICI)1097-4636(19990315)44:4<446::AID-JBM11>3.0.CO;2-F ↗
43. 10.1016/j.biomaterials.2003.12.00510.1016/j.biomaterials.2003.12.005 ↗
44. 10.1016/j.actbio.2005.06.00510.1016/j.actbio.2005.06.005 ↗
45. 10.1155/2012/19095010.1155/2012/190950 ↗
46. 10.1007/s10934-011-9458-910.1007/s10934-011-9458-9 ↗
47. 10.1016/0021-9290(94)90056-610.1016/0021-9290(94)90056-6 ↗
48. 10.1016/j.bone.2011.06.03510.1016/j.bone.2011.06.035 ↗
49. 10.1016/0021-9290(91)90006-910.1016/0021-9290(91)90006-9 ↗
50. Chodak I. · 2008
51. 10.1089/ten.teb.2009.041610.1089/ten.teb.2009.0416 ↗
52. 10.1016/j.actbio.2017.08.01510.1016/j.actbio.2017.08.015 ↗
53. 10.1016/j.biomaterials.2005.01.00610.1016/j.biomaterials.2005.01.006 ↗
54. 10.1007/s00467-012-2175-z10.1007/s00467-012-2175-z ↗
55. 10.1016/j.biomaterials.2011.01.00410.1016/j.biomaterials.2011.01.004 ↗
56. 10.1016/j.drudis.2018.01.04910.1016/j.drudis.2018.01.049 ↗
57. 10.1007/s10853-017-1010-010.1007/s10853-017-1010-0 ↗
58. 10.3390/ma1213207910.3390/ma12132079 ↗
59. 10.1016/j.msec.2018.12.00610.1016/j.msec.2018.12.006 ↗
60. 10.1016/j.msec.2019.10991010.1016/j.msec.2019.109910 ↗
61. 10.3390/ma1312281910.3390/ma13122819 ↗
62. 10.3390/MA1308181610.3390/MA13081816 ↗
63. 10.3390/app1016553010.3390/app10165530 ↗
64. 10.3390/ma1221363310.3390/ma12213633 ↗
65. 10.1021/am402089w10.1021/am402089w ↗
66. 10.1016/j.biomaterials.2011.12.02410.1016/j.biomaterials.2011.12.024 ↗
67. 10.1038/s41368-020-0073-y10.1038/s41368-020-0073-y ↗
68. 10.1007/s11706-012-0154-810.1007/s11706-012-0154-8 ↗
69. 10.1016/j.biomaterials.2003.08.04310.1016/j.biomaterials.2003.08.043 ↗
70. 10.1152/jappl.2000.89.1.16910.1152/jappl.2000.89.1.169 ↗